{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T21:23:42Z","timestamp":1775856222504,"version":"3.50.1"},"reference-count":1,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T00:00:00Z","timestamp":1093564800000},"content-version":"vor","delay-in-days":57,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2004,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Seborrheic dermatitis is a common inflammatory skin disorder. Although the precise etiology of seborrheic dermatitis is uncertain, yeasts of the genus <jats:italic>Malassezia<\/jats:italic> have been implicated. Ciclopirox is a broad\u2010spectrum, hydroxypyridone\u2010derived, synthetic antifungal agent with anti\u2010inflammatory properties.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> A total of 183 patients were enrolled in this randomized, parallel\u2010group, double\u2010blind, vehicle\u2010controlled trial designed to compare three different application frequencies of ciclopirox 1% shampoo: once, twice, and three times weekly. The main efficacy parameters were based on 6\u2010point ordinal scales describing the disease's signs and symptoms (scaling, inflammation and itching), global status of seborrheic dermatitis, and global change of seborrheic dermatitis.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Each application frequency of ciclopirox 1% shampoo was found to significantly improve the signs and symptoms of seborrheic dermatitis of the scalp after 4\u00a0weeks of treatment. Furthermore, the therapeutic index calculated from the global change in seborrheic dermatitis score increased with increasing application frequency; therapeutic index scores increased from vehicle (1.25) to ciclopirox 1% once (3.30), twice (3.50), and three times (3.56) weekly. No serious adverse events were recorded during the course of the study.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> Ciclopirox 1% shampoo, applied once, twice or three times weekly, is a safe and acceptable preparation that improves seborrheic dermatitis of the scalp, suggesting that this is an alternative treatment for this indication.<\/jats:p>","DOI":"10.1111\/j.1461-1244.2004.02382.x","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T09:30:56Z","timestamp":1093599056000},"page":"13-16","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: Results of a double\u2010blind, placebo\u2010controlled study comparing the efficacy of once, twice, and three times weekly usage"],"prefix":"10.1111","volume":"43","author":[{"given":"Dietrich","family":"Abeck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"on behalf of the Loprox Shampoo Dosing Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,8,27]]},"reference":[{"key":"e_1_2_6_2_2","unstructured":"CauwenberghG.International experience with ketoconazole shampoo in the treatment of seborrheic dermatitis and dandruff. In:ShusterS BlatchfordN eds.Seborrheic Dermatitis and Dandruff \u2013 a Fungal Disease (International Congress and Symposium Series No. 132).London: Royal Society of Medicine Services 1988;35\u201345."}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1461-1244.2004.02382.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1461-1244.2004.02382.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,10]],"date-time":"2023-10-10T04:50:17Z","timestamp":1696913417000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1461-1244.2004.02382.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,7]]},"references-count":1,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2004,7]]}},"alternative-id":["10.1111\/j.1461-1244.2004.02382.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1461-1244.2004.02382.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,7]]},"assertion":[{"value":"2004-08-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}